Day One Biopharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $39,795 | $33,908 | $30,761 | $29,208 |
Gross Profit | 35,315 | 30,143 | 27,877 | 26,226 |
EBITDA | -18,787 | -29,358 | -35,102 | -58,480 |
EBIT | -19,726 | -30,322 | -35,996 | -59,239 |
Net Income | -19,726 | -30,322 | -35,996 | -65,714 |
Net Change In Cash | 39,795 | 33,908 | 30,761 | 29,208 |
Free Cash Flow | -5,805 | -21,309 | -62,814 | -31,427 |
Cash | 43,277 | 35,622 | 33,358 | 124,968 |
Basic Shares | 103,381 | 103,069 | 102,710 | 93,623 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $131,161 | $0 | $0 | $0 |
Gross Profit | 125,882 | -383 | -531 | -199 |
EBITDA | -86,323 | -188,534 | -146,378 | -72,544 |
EBIT | -88,352 | -188,917 | -146,909 | -72,743 |
Net Income | -95,496 | -188,917 | -132,176 | -70,442 |
Net Change In Cash | 131,161 | 0 | 0 | 0 |
Cost of Revenue | -199,047 | 240,581 | ||
Free Cash Flow | -80,282 | -150,077 | -109,900 | -56,539 |
Cash | 124,968 | 230,784 | 85,262 | 284,309 |
Basic Shares | 93,623 | 79,773 | 65,466 | 61,952 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.19 |
2025-06-30 | -$0.29 |
2025-03-31 | -$0.35 |
